|
1
|
Hasselgren PO: Prevention and treatment of
ischemia of the liver. Surg Gynecol Obstet. 164:187–196.
1987.PubMed/NCBI
|
|
2
|
Lemasters JJ and Thurman RG: Reperfusion
injury after liver preservation for transplantation. Annu Rev
Pharmacol Toxicol. 37:327–338. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Olthoff KM: Can reperfusion injury of the
liver be prevented? Trying to improve on a good thing. Pediatr
Transplant. 5:390–393. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dogan S and Aslan M: Hepatic
ischemia-reperfusion injury and therapeutic strategies to alleviate
cellular damage. Hepatol Res. 41:103–117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Colletti LM, Kunkel SL, Walz A, Burdick
MD, Kunkel RG, Wilke CA and Strieter RM: The role of cytokine
networks in the local liver injury following hepatic
ischemia/reperfusion in the rat. Hepatology. 23:506–514. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jaeschke H, Farhood A and Smith CW:
Neutrophils contribute to ischemia/reperfusion injury in rat liver
in vivo. FASEB J. 4:3355–3359. 1990.PubMed/NCBI
|
|
7
|
Bates EJ, Ferrante A, Smithers L, Poulos A
and Robinson BS: Effect of fatty acid structure on neutrophil
adhesion, degranulation and damage to endothelial cells.
Atherosclerosis. 116:247–259. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
De Caterina R, Liao JK and Libby P: Fatty
acid modulation of endothelial activation. Am J Clin Nutr. 71(1
Suppl): 213S–223S. 2000.PubMed/NCBI
|
|
9
|
Wall R, Ross RP, Fitzgerald GF and Stanton
C: Fatty acids from fish: The anti-inflammatory potential of
long-chain omega-3 fatty acids. Nutr Rev. 68:280–289. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Serhan CN, Chiang N and Van Dyke TE:
Resolving inflammation: Dual anti-inflammatory and pro-resolution
lipid mediators. Nat Rev Immunol. 8:349–361. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marsman HA, Heger M, Kloek JJ, Nienhuis
SL, ten Kate FJ and van Gulik TM: Omega-3 fatty acids reduce
hepatic steatosis and consequently attenuate ischemia-reperfusion
injury following partial hepatectomy in rats. Dig Liver Dis.
43:984–990. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Coelho AM, Machado MC, Takahashi HK,
Sampietre SN, Stefano JT, Leite AZ, Curi R and D'Albuquerque LA:
Ischemic preconditioning-like effect of polyunsaturated fatty
acid-rich diet on hepatic ischemia/reperfusion injury. J
Gastrointest Surg. 15:1679–1688. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zúñiga J, Cancino M, Medina F, Varela P,
Vargas R, Tapia G, Videla LA and Fernández V: N-3 PUFA
supplementation triggers PPAR-α activation and PPAR-α/NF-κB
interaction: Anti-inflammatory implications in liver
ischemia-reperfusion injury. PLoS One. 6:e285022011. View Article : Google Scholar
|
|
14
|
Zhu XH, Wu YF, Qiu YD, Jiang CP and Ding
YT: Liver-protecting effects of omega-3 fish oil lipid emulsion in
liver transplantation. World J Gastroenterol. 18:6141–6147. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dogan S, Ozlem Elpek G, Kirimlioglu Konuk
E, Demir N and Aslan M: Measurement of intracellular biomolecular
oxidation in liver ischemia-reperfusion injury via immuno-spin
trapping. Free Radic Biol Med. 53:406–414. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Curek GD, Cort A, Yucel G, Demir N, Ozturk
S, Elpek GO, Savas B and Aslan M: Effect of astaxanthin on
hepatocellular injury following ischemia/reperfusion. Toxicology.
267:147–513. 2010. View Article : Google Scholar
|
|
17
|
Yilmaz S, Ates E, Tokyol C, Pehlivan T,
Erkasap S and Koken T: The protective effect of erythropoietin on
ischaemia/reperfusion injury of liver. HPB (Oxford). 6:169–173.
2004. View Article : Google Scholar
|
|
18
|
Aslan M, Aslan I, Özcan F, Eryılmaz R,
Ensari CO and Bilecik T: A pilot study investigating early
postoperative changes of plasma polyunsaturated fatty acids after
laparoscopic sleeve gastrectomy. Lipids Health Dis. 13:622014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Aslan M, Özcan F, Aslan I and Yücel G:
LC-MS/MS analysis of plasma polyunsaturated fatty acids in type 2
diabetic patients after insulin analog initiation therapy. In:
Lipids Health Dis. 12. pp. 1692013
|
|
20
|
van Gulik TM, de Graaf W, Dinant S, Busch
OR and Gouma DJ: Vascular occlusion techniques during liver
resection. Dig Surg. 24:274–281. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ozer J, Ratner M, Shaw M, Bailey W and
Schomaker S: The current state of serum biomarkers of
hepatotoxicity. Toxicology. 245:194–205. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Calder PC: Polyunsaturated fatty acids,
inflammation and immunity. Lipids. 36:1007–1024. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Setty BN, Dampier CD and Stuart MJ:
Arachidonic acid metabolites are involved in mediating red blood
cell adherence to endothelium. J Lab Clin Med. 125:608–617.
1995.PubMed/NCBI
|
|
24
|
Besse T, Gustin T, Claeys N, Schroeyers P
and Lambotte L: Effect of PGI2 and thromboxane antagonist on liver
ischemic injury. Eur Surg Res. 21:213–217. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Post S, Goerig M, Otto G, Manner M,
Senninger N, Kommerell B and Herfarth C: Prostanoid release in
experimental liver transplantation. Transplantation. 49:490–494.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Post S, Goerig M, Otto G, Manner M, Foltis
C, Hofmann W and Herfarth C: Rapid increase in the activity of
enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues
after experimental liver transplantation. Transplantation.
51:1058–1065. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koike K, Yamamoto Y, Hori Y and Ono T:
Group IIA phospholipase A2 mediates lung injury in intestinal
ischemia-reperfusion. Ann Surg. 232:90–97. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ogata K, Jin MB, Taniguchi M, Suzuki T,
Shimamura T, Kitagawa N, Magata S, Fukai M, Ishikawa H, Ono T, et
al: Attenuation of ischemia and reperfusion injury of canine livers
by inhibition of type II phospholipase A2 with LY329722.
Transplantation. 71:1040–1046. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Murakami M and Kudo I: Phospholipase A2. J
Biochem. 131:285–292. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Menschikowski M, Hagelgans A and Siegert
G: Secretory phospholipase A2 of group IIA: Is it an offensive or a
defensive player during atherosclerosis and other inflammatory
diseases? Prostaglandins Other Lipid Mediat. 79:1–33. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dan P, Nitzan DW, Dagan A, Ginsburg I and
Yedgar S: H2O2 renders cells accessible to
lysis by exogenous phospholipase A2: A novel mechanism for cell
damage in inflammatory processes. FEBS Lett. 383:75–78. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Murakami M, Nakatani Y, Atsumi G, Inoue K
and Kudo I: Regulatory functions of phospholipase A2. Crit Rev
Immunol. 17:225–283. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Nanji AA, Miao L, Thomas P, Rahemtulla A,
Khwaja S, Zhao S, Peters D, Tahan SR and Dannenberg AJ: Enhanced
cyclo-oxygenase-2 gene expression in alcoholic liver disease in the
rat. Gastroenterology. 112:943–951. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Planagumà A, Clària J, Miquel R,
López-Parra M, Titos E, Masferrer JL, Arroyo V and Rodés J: The
selective cyclooxy-genase-2 inhibitor SC-236 reduces liver fibrosis
by mechanisms involving non-parenchymal cell apoptosis and
PPARgamma activation. FASEB J. 19:1120–1122. 2005.
|
|
35
|
Waris G and Siddiqui A: Hepatitis C virus
stimulates the expression of cyclooxygenase-2 via oxidative stress:
Role of pros-taglandin E2 in RNA replication. J Virol.
79:9725–9734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim SH and Lee SM: Expression of hepatic
vascular stress genes following ischemia/reperfusion and subsequent
endotoxemia. Arch Pharm Res. 27:769–775. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Breyer RM, Bagdassarian CK, Myers SA and
Breyer MD: Prostanoid receptors: Subtypes and signaling. Annu Rev
Pharmacol Toxicol. 41:661–690. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wanner GA, Müller P, Ertel W, Busch CJ,
Menger MD and Messmer K: Differential effect of cyclooxygenase
metabolites on proinflammatory cytokine release by Kupffer cells
after liver ischemia and reperfusion. Am J Surg. 175:146–151. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Arai M, Peng XX, Currin RT, Thurman RG and
Lemasters JJ: Protection of sinusoidal endothelial cells against
storage/reperfusion injury by prostaglandin E2 derived from Kupffer
cells. Transplantation. 68:440–445. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Masaki N, Ohta Y, Shirataki H, Ogata I,
Hayashi S, Yamada S, Hirata K, Nagoshi S, Mochida S, Tomiya T, et
al: Hepatocyte membrane stabilization by prostaglandins E1 and E2:
Favorable effects on rat liver injury. Gastroenterology.
102:572–576. 1992.PubMed/NCBI
|
